Hematology & Coagulation Billing Services That Capture Every Test You Perform

Hematology and coagulation testing runs on methodology distinctions that generalist billers routinely flatten into a single code. Automated versus manual differentials, bundled coagulation panels, frequency-limited CBCs, and anticoagulation monitoring rules each carry their own reimbursement logic and each one is a place where revenue quietly disappears. TransLabs’ hematology-certified coders close those gaps with a 98% clean claims rate and 28% faster A/R, with measurable recovery inside 90 days.
Hematology & Coagulation Billing Services
0%
Client Retention Rate
0%
First-Pass Claim Rate
0%
Avg. Revenue Growth
0%
Avg. Denial Reduction

Why Hematology & Coagulation Labs Lose Revenue Every Single Day

Hematology and coagulation billing isn’t chemistry billing with different CPT codes. Differential methodology, reflex smear protocols, factor assay documentation, and anticoagulation monitoring create coding traps; 85025 for 85027, or 85610 without ICD-10, that generalists never recognize as a pattern. The loss isn’t one event; it’s a slow bleed across thousands of low-dollar claims nobody’s watching.

The Five Revenue Leaks Most Hematology & Coagulation Labs Don't Know They Have

Automated Versus Manual Differential Confusion

CBC Frequency Limit Violations

Missed Reflex-to-Manual-Differential Revenue

Coagulation Panel Component Miscoding

Home INR and Anticoagulation Monitoring Coding Errors

Every Hematology & Coagulation Test Category, Billed With Methodology Precision

From routine CBCs run on high-throughput hematology analyzers to manually reviewed peripheral smears and molecular markers for hematologic malignancy, our AAPC and AHIMA certified coders know the methodology distinctions, the NCCI bundling rules, and the payer-specific frequency limits for every category of hematology and coagulation testing.

Complete Blood Count & Differential Testing

CPT 85002–85049

Complete blood count with automated differential (85025), CBC without differential (85027), manual differential (85007), each component alone — hematocrit (85014), hemoglobin (85018), WBC count (85048), platelet count (85049) — and reticulocyte count (85045).

Key Billing Consideration

85025, 85027, and the individual component codes cannot be billed together on the same date under NCCI; the deciding factor is whether the order specifically requested a differential, and that distinction alone drives most CBC-related denials.

Coagulation & Hemostasis Studies

CPT 85210–85385

Prothrombin time PT/INR (85610), partial thromboplastin time PTT (85730), thrombin time (85670), fibrinogen (85384), D-dimer (85379), factor assays (85240–85293), von Willebrand studies, and lupus anticoagulant evaluation (85613).

Key Billing Consideration

Factor assay claims require documentation linking the specific factor tested to a clinical indication such as unexplained bleeding, pre-surgical workup, or known factor deficiency; missing that linkage is one of the most frequent medical-necessity denial triggers in coagulation billing.

Specialized Hematology & Bone Marrow Studies

CPT 85060–85097, 38220–38222

Peripheral blood smear interpretation (85060), bone marrow aspiration (38220), bone marrow biopsy (38221), combined aspiration and biopsy (38222), iron stain (85536), and cytochemical staining for leukemia workup.

Key Billing Consideration

Bone marrow procedure codes and their associated pathology interpretation must be billed with the correct technical/professional split, and bundling edits apply when aspiration and biopsy are performed at the same session without the combined code.

Platelet Function & Bleeding Disorder Testing

CPT 85576–85597

Platelet aggregation studies (85576), platelet function assay / PFA (85576, 85597), heparin-induced thrombocytopenia antibody testing (85306), and ristocetin cofactor assays for von Willebrand disease.

Key Billing Consideration

Platelet function testing carries payer-specific prior authorization requirements in many commercial plans, and claims submitted without a documented bleeding history or pre-procedure indication are routinely denied for lack of medical necessity.

Molecular & Genetic Hematology Markers

CPT 81206–81279, 88184–88189

BCR-ABL1 quantitative PCR (81206–81208), JAK2 mutation analysis (81279), flow cytometry for leukemia and lymphoma immunophenotyping (88184–88189), and PNH clone testing by flow cytometry.

Key Billing Consideration

Molecular hematology and flow cytometry codes are billed per antibody or per marker studied, not as a flat panel fee, and payer medical policies frequently require a confirmed or suspected malignancy diagnosis before authorizing reimbursement.

Anticoagulation Monitoring & Home INR Testing

CPT HCPCS G0248–G0250

Home INR monitor demonstration and training (G0248), provision of home INR test materials billed per four tests (G0249), and physician review and interpretation of home INR results billed per four tests (G0250).

Key Billing Consideration

Coverage is limited to patients with a mechanical heart valve, chronic atrial fibrillation, or venous thromboembolism, and G0249 cannot be billed more often than weekly — exceeding that frequency or billing G0250 without documented physician review is a recurring denial pattern in Coumadin clinic billing.

Our Laboratory RCM Services

TransLabs’ specialized RCM services are built exclusively for labs, addressing the unique challenges that generalist billers miss. We provide end-to-end revenue cycle solutions designed specifically to turn laboratory complexity into profitability.

Proficient Across Multiple LIS & EHRs to Simplify Your
Laboratory Management

ChartLogic
Collaborate md
Greenway health
Haemonetics
jane
cgm Labdaq
Modmed
open emr
Harris Data Integrity Solutions
siemens healthineers
Tebra
Oracle Health
Confience
Power path
Benchmark solutions
Xifin
Psyche Systems
veradigm
Turemed Lis
Telcor
Practice pro
novo path
Nextgen Healthcare
Next tech
meditech
Advanced data systems corporation
Logilab
Labware
Lab vantage
labs os
Epic
Dr Chrono
dendi
Corepoint
clinisys
Care Cloud
apex healthware
clinisys copathplus
Advanced md
softlab
athenaone

Serving Labs Across The United States

TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.

Medicare Part B Compliance for Hematology & Coagulation Testing

Hematology and coagulation billing under Medicare Part B carries frequency rules, methodology distinctions, and anticoagulation monitoring requirements that catch generalist billing companies off guard on a routine basis. The combination of Local Coverage Determinations, NCCI bundling edits, frequency limitations, and home INR monitoring criteria requires dedicated, proactive management.
Local Coverage Determinations (LCDs)

Each Medicare Administrative Contractor maintains its own LCD specifying which ICD-10 codes support coverage for CBCs, coagulation studies, and molecular hematology markers. TransLabs maintains live LCD databases for every MAC and validates diagnosis code linkage on every hematology and coagulation claim before submission.

Frequency Limitations

CPT 85025 is generally limited to once every 90 days for chronic condition monitoring, and home INR testing under G0249 cannot be billed more often than weekly. TransLabs tracks each patient's claim history against these limits and alerts ordering providers before a frequency cap is reached.

NCCI Bundling Edits

Automated and manual differential codes, individual CBC components, and certain coagulation panel components are subject to National Correct Coding Initiative edits that prevent same-date billing. TransLabs runs every hematology and coagulation claim through an NCCI edit check before it leaves our system, not after a denial arrives.

Advance Beneficiary Notices (ABNs)

When a beneficiary requests a coagulation or molecular hematology test that may not meet medical necessity criteria under the applicable LCD, a valid ABN must be issued before the test is performed. TransLabs builds ABN workflows into front-end registration so the documentation is always in place.

Clinical Laboratory Fee Schedule (CLFS)

The CLFS sets Medicare payment rates for CBC, coagulation, and hematology panel codes and updates annually on January 1. TransLabs monitors CLFS changes, updates billing tables immediately, and flags payers reimbursing below CLFS rates.

PAMA Reporting Requirements

Labs meeting the applicable laboratory definition under PAMA carry mandatory private payer data reporting obligations, and hematology and coagulation test volumes are frequently part of that reporting base. TransLabs tracks these obligations and ensures reporting deadlines are met.

OIG Work Plan Monitoring

Genetic and molecular hematology testing — including BCR-ABL and JAK2 panels — has drawn increased OIG scrutiny in recent audit cycles. TransLabs builds compliance protocols specifically around current OIG focus areas to reduce your audit exposure before it becomes a problem.

We Bill Hematology & Coagulation Testing Exclusively, and the Accuracy Shows

Hematology and coagulation billing has its own methodology, NCCI bundling rules, anticoagulation codes, and frequency limits. TransLabs was built for lab billing; coders stay in hematology and coagulation; not chemistry one week, coagulation next.

Hematology & Coagulation-Exclusive Coding Teams

Your coders specialize in hematology and coagulation; differentials, factor assays, anticoagulation monitoring, not every lab discipline at once.

98% First-Pass Clean Claims Rate

98%+ clean claims rate across all lab clients with fewer denials, faster payments, stronger cash flow.

Differential Methodology Engine

Automated logic flags differential mismatches and missed reflex opportunities before claims go out; revenue most labs never knew they were missing.

Anticoagulation Clinic Billing Expertise

We bill the G0248/G0249/G0250 home INR code set right the first time; frequency, documentation, all of it.

No Long-Term Contracts

Month-to-month, results-based partnership with measurable improvement in 90 days, no exit fees, just 30 days’ notice.

Transparent Reporting

Monthly dashboards with full visibility of clean claims rate, denial trends, A/R aging, and root cause analysis, no surprises.

Get Your Hematology & Coagulation Lab's Custom Revenue Recovery Plan

Schedule a call with our hematology and coagulation billing specialist. We’ll review your differential coding, coagulation panel optimization, anticoagulation monitoring compliance, and A/R days.

What Our Clients Say?

Linda Hutchinson
Linda Hutchinson
Laboratory Director
Our NGS panel denials dropped from 32% to under 6% within three months. TransLabs' expertise with molecular tier codes, prior authorization management, and LCD compliance has been invaluable. They understand the nuances of genetic testing billing that our previous vendor completely missed.
Peter Wozniak
Peter Wozniak
Pathologist & Laboratory Owner
We've worked with three other billing companies over the years. TransLabs is the only one that truly understands complex surgical pathology coding, immunohistochemistry billing, and the nuances of TC/PC modifiers. Clean claims rate improved to 99%, and our dermatopathology reimbursement increased 27%.
James Patton
James Patton
Cytogenetics Laboratory Manager
Before TransLabs, our FISH and karyotype claims were a constant struggle with denials and underpayments. Their coders actually understand probe configurations, complexity levels, and when to use 88271 versus 88275. Our cytogenetics revenue increased 34% in the first year.

Book Consultation Today!

Stop Leaving Hematology & Coagulation Reimbursements on the Table

Join 300+ hematology reference labs, coagulation testing centers, and anticoagulation clinics that trust TransLabs, the laboratory billing company built for growth. Start with our complimentary claims audit. Our hematology and coagulation billing specialists will review your CPT/HCPCS coding, differential methodology, and denial trends to show you exactly what’s recoverable.

Dedicated hematology & coagulation billing specialist assigned to your lab

Complimentary 12-month claims audit across Medicare, Medicaid, and commercial payers

Uncover your top 3 revenue leaks in differential coding, factor assays, and anticoagulation monitoring

Custom strategy tailored to your analyzer platform and LIS/billing software

Live in 24 hours with no contracts and no upfront fees

Pay only a percentage of what we collect for you

Frequently Asked Questions

What's the difference between billing CPT 85025 and 85027?

85025 is a complete blood count with an automated differential; 85027 is a CBC without a differential. The determining factor is what the ordering provider’s documentation actually requested; if the order doesn’t specify a differential, billing 85025 anyway is one of the most common hematology denial triggers.

Coagulation tests like factor assays and lupus anticoagulant panels require documentation tying the specific test to a clinical indication such as unexplained bleeding or a known deficiency. Chemistry panels rarely carry that same indication-specific requirement, which is why generalist billers underestimate coagulation documentation needs.
Home INR monitoring uses three HCPCS codes: G0248 for the initial demonstration, G0249 for provision of test materials billed per four tests and no more than weekly, and G0250 for physician review billed per four tests. Coverage requires a mechanical heart valve, chronic atrial fibrillation, or venous thromboembolism diagnosis.
Medicare generally allows CPT 85025 once every 90 days for chronic condition monitoring such as anemia. More frequent testing is covered when the chart documents an acute clinical change or an active chemotherapy protocol requiring closer monitoring.
Generally no. NCCI edits prevent 85025 and 85007 from being billed together for the same date of service in most circumstances, even when a reflex manual review followed an abnormal automated result. TransLabs’ coding logic identifies when the reflex add-on is separately billable versus bundled.
Factor assay claims need a clinical indication in the chart; unexplained bleeding, pre-surgical clearance, or a known or suspected factor deficiency, linked to the specific factor tested. Claims submitted without that linkage are a leading cause of medical necessity denials in coagulation billing.
Yes, including BCR-ABL1 quantitative PCR, JAK2 mutation analysis, and flow cytometry immunophenotyping for leukemia and lymphoma workups. These codes are billed per marker or antibody studied, and payer policies typically require a confirmed or suspected malignancy diagnosis.
Most hematology and coagulation labs see measurable improvement within 60–90 days: differential coding corrections and NCCI edit checks are live within the first 30 days, denial rate improvement follows by day 60, and by day 90 clients typically see a 98% clean claims rate with documented revenue recovery from previously missed reflex and factor assay charges.

Your Trusted Lab Billing Partner

Book Your Free Consultation

Book Consultation Today!

Book Consultation Today!